FDA Suspension Of Drug Approval Needs To Be Easier, Task Force Suggests

FDA should seek a reduction in the "imminent hazard" standard for removing drug products from the market, FDA's Task Force on Risk Management suggests in its May 10 report to Commissioner Henney.